Classification of antituberculosis drugs: a new proposal based on the most recent evidence

Eur Respir J. 2015 Oct;46(4):887-93. doi: 10.1183/13993003.00432-2015.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / classification*
  • Carbapenems / administration & dosage
  • Clavulanic Acid / administration & dosage
  • Clofazimine / administration & dosage
  • Diarylquinolines / administration & dosage
  • Drug Therapy, Combination
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Humans
  • Infectious Disease Medicine / methods
  • Infectious Disease Medicine / standards*
  • Linezolid / administration & dosage
  • Nitroimidazoles / administration & dosage
  • Oxazoles / administration & dosage
  • Practice Guidelines as Topic
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents
  • Carbapenems
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • Clavulanic Acid
  • bedaquiline
  • Clofazimine
  • Linezolid